NEW YORK, Jan. 5 (GenomeWeb News) - Cetek raised $10 million from investors to advance its drug-discovery platform, the company said earlier this week.
Participating investors include Argonaut Private Equity, Ventry Industries, Gainesborough Investments, James L. Waters, and Stata Ventures. They are all current Cetek investors.
Cetek approaches drug discovery using high throughput capillary electrophoresis screening technology and chemical biology-focused drug source. The company said it uses its technologies through service agreements and collaborations.
The Marlborough, Mass-based company also announced a scientific advisory board. The chairman of the board is Cetek founder Barry L. Karger. Other members include K. Frank Austen from Harvard Medical School, James D. Griffin from Harvard Medical School, Charles L. Cooney, from the MIT Program on the Pharmaceutical Industry, and Martin S. Hirsch from Harvard School of Public Health; and Infectious Disease Service at the Massachusetts General Hospital.